New (and improved) diabetes meds for heart and kidney disease
Often, in the world of medicine, progress is made in unexpected ways. Researchers sometimes find solutions to problems not by carefully planned experiments but by happy accidents. A prime example of this is in recent advancements in treating heart and kidney disease with new families of medications initially intended to treat people with type 2 […]
If it brings such great benefits, why do people stop taking Ozempic?
A natural question has arisen. “If they have such great benefits and are so popular, why do people stop taking Ozempic, Mounjaro and Wegovy?” Ozempic and Mounjaro are considered “wonder drugs” out of all the treatments for type 2 diabetes, which have brought significant benefits to millions of people worldwide who develop type 2 diabetes and caused […]
Why is Ozempic so expensive?
There is a widely-held public view that drug companies and pharmacies in the US gouge the public relentlessly without care for the public good or ethics. From that perspective, the complaint is that the only thing that matters to the companies is their bank balances. One of the unfortunate targets of this prevailing thinking is […]
Diabetes Alert Day: Treatment and Prevention
What is Diabetes Alert Day? Since 1987, the American Diabetes Association has named the 4th Tuesday in March as Diabetes Alert Day. This year it falls on March 28th. Diabetes Alert Day was created as a public “wake-up call” to the seriousness of diabetes and the importance of understanding the associated risks of living with […]
FDA approves a new type 2 diabetes drug that works in combination with Metformin
On January 20th, the FDA announced approval of a new sodium-glucose cotransporter 2 (SGLT2) inhibitor for treatment of type 2 diabetes in adults. The new drug is produced by Theracos, a privately held pharmaceutical research and development company located in Marlborough, Massachusetts. The drug will be marketed under the name Brenzavvy (generic name: bexagliflozin). The […]
Introducing the new once-a-day pill for Type 2 diabetes that replaces weekly injections
In 2017, a new drug came onto the market that radically improved therapy for adult sufferers of Type 2 diabetes. That new treatment is a once-a-week self-injectable dose of Ozempic, and it contains a newly developed drug called semaglutide. Now, the drug company Novartis that developed Ozempic has released a pill-form of semaglutide that can […]
November is National Diabetes Month
November is National Diabetes Month. In 2022, the theme is sharing ways you can work with health care professionals to build a team to help you manage your diabetes. The Center for Disease Control and Prevention lists some of the most common dangers that come with diabetes as: Heart disease and stroke. People with diabetes […]
